The location of the tumors and the presence of intestinal metaplasia with goblet cells suggest the carcinoma lineage of the tumor which is in line with prior results demonstrating concurrence of Barrett esophagus with this lesion.12 Moreover, further testing of BRG1 loss supports the diagnosis of SMARCA4-UT. The gene discussed is SMARCA4; the disease is esophageal adenocarcinoma.